Toboroz
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
NCT07768189· 3. fázis· Corbus Pharmaceuticals Inc.· Forrás
Contact: Robert Metcalf, MD (principal investigator)
Toboroz
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995· 3. fázis· BioNTech SE· Forrás
Toboroz
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Prof
Toboroz
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
NCT05770544· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Toboroz
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
NCT07070232· 1/2. fázis· BioNTech SE· Forrás
Toboroz
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
NCT06827236· 1/2. fázis· BioNTech SE· Forrás
Toboroz
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT06819007· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
NCT06556563· 3. fázis· NovoCure GmbH· Forrás
Fut, nem toboroz
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
NCT06635824· 3. fázis· Genmab· Forrás
Toboroz
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT06988475· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Toboroz
Personalized Medicine for Advanced Biliary Cancer Patients
NCT05615818· 3. fázis· UNICANCER· Forrás
Contact: Mairead MCNAMARA, MD
Fut, nem toboroz
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
NCT06388733· 3. fázis· Ivy Brain Tumor Center· Forrás
Toboroz
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT06045910· 1/2. fázis· Cancer Research UK· Forrás
Contact: Adam Gibb, Dr
Toboroz
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
NCT05770037· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Fut, nem toboroz
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
NCT05004064· 2. fázis· University College, London· Forrás
Toboroz
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT05770102· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Toboroz
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT05882058· 2. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
HTL0039732 in Participants With Advanced Solid Tumours
NCT05944237· 1/2. fázis· Cancer Research UK· Forrás
Contact: Natalie Cook, Dr
Toboroz
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143· Sirtex Medical· Forrás
Contact: Saifee Mullamitha (principal investigator)
Toboroz
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT05786716· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Toboroz
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT05722886· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Toboroz
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
NCT05768178· 2/3. fázis· Cancer Research UK· Forrás
Contact: Matthew Krebs, Dr
Fut, nem toboroz
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795· 3. fázis· Day One Biopharmaceuticals, Inc.· Forrás
Fut, nem toboroz
Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
NCT05315258· 2. fázis· University of Oxford· Forrás
Fut, nem toboroz
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT05057013· 1/2. fázis· Cancer Research UK· Forrás
Fut, nem toboroz
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
NCT04546620· 2. fázis· University Hospital Southampton NHS Foundation Trust· Forrás
Fut, nem toboroz
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004· 2. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
NCT04656652· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT04663347· 1/2. fázis· Genmab· Forrás
Toboroz
Study to Evaluate the Safety and Tolerability of EP0042
NCT04581512· 1/2. fázis· Ellipses Pharma· Forrás
Contact: Clinical Trials Team
Toboroz
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597· 1/2. fázis· CellCentric Ltd.· Forrás
Contact: Tim Somervaille
Fut, nem toboroz
Stereotactic Body Radiotherapy for the Treatment of OPD
NCT03256981· 2/3. fázis· Institute of Cancer Research, United Kingdom· Forrás
Fut, nem toboroz
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
NCT02406222· 2. fázis· University of Leeds· Forrás